Our Science
Driving innovation through cutting-edge research and development.
Pipeline
Our robust pipeline targets a wide range of serious diseases. We focus on areas of high unmet medical need, leveraging our proprietary technologies to accelerate development.
Explore our investigational medicines currently in clinical trials.
Explore our investigational medicines currently in clinical trials.

Research & Development
R&D is the cornerstone of NMGRs. Our scientists are committed to rigorous investigation and discovery across multiple therapeutic areas. We invest significantly in understanding disease biology to identify novel targets and develop potentially transformative therapies.
Our integrated approach combines expertise in genetics, molecular biology, and clinical development.
Our integrated approach combines expertise in genetics, molecular biology, and clinical development.
Technologies
NMGRs utilizes a suite of proprietary technologies, including our advanced antibody development platform and high-throughput genetic sequencing capabilities. These tools enable rapid discovery and validation of therapeutic candidates.

NMGRs Genetics CenterĀ®
The NMGRs Genetics CenterĀ® (BGC) is a leader in large-scale human genetics research. By analyzing genetic data alongside clinical information, the BGC provides critical insights into the biological mechanisms of disease, informing drug discovery and development across our pipeline.